The OSCAR project is a public/private partnership, where all partners are equal in the project. The partners have signed a detailed agreement on the distribution of roles and assignments in the project.

The OSCAR project is a public/private partnership, where all partners are equal in the project. The partners have signed a detailed agreement on the distribution of roles and assignments in the project.

The Steering Committee
The highest authority in the OSCAR project is the steering committee. All project partners are represented in the steering committee. Professor and Chief Consultant Urlik Lassen, Oncology Department at Rigshospitalet, is the head of the steering committee. Significant decisions made by the Steering Committee must subsequently be approved by the Danish Innovation Fund. The Steering Committee will meet as often as needed and up to 4 times a year.


OSCAR is supported by seven equal public and private partners, working together to develop and test new technology and innovative models for accessing Danish health data that also ensure personal data privacy protection.
Datafair logo
DataFair is the project leader on the OSCAR project. DataFair is responsible for developing a data model and business model for OSCAR based on a Public/Private Partnership. DataFair carries the responsibility that the solutions developed and tested in the project can be continued after the project is finished and continue to create value in terms of Danish health data for patients, citizens, the health care system, researchers and companies going forward.
Partisia’s solutions are based on Secure Multiparty Computation technology. Partisia is responsible for developing and running the Virtual Public Register solution for encryption and sharing of public health data and the DATA for GOOD Platform for encryption and sharing of private data.
Enversion logo
Enversion is responsible for cleaning and structuring health data that is to be combined, encrypted and analysed by Secata’s VPR solution.
Silvi logo
Silvi is responsible for ensuring that the knowledge from scientific publications can be made available in a format that enables its combination with other health data.  
Rigshospitalet logo
In the OSCAR project, Rigshospitalet will carry out the clinical research project, Copenhagen Master Observational Trial (C-MOT). In the research project, data from 1,800 patients with breast cancer and 800 patients with lung cancer will be gathered. These data will be combined with existing data on the patients and, based on this knowledge, Rigshospitalet will gain better insight into the effect of treatments that are tailored to the individual cancer patient.
Amgros logo
In the OSCAR project, Amgros will contribute to the identification and collection of a relevant data pool, which can be utilized for working with innovative and value-based pricing agreements on therapeutics. They will also be tasked with testing selected innovative pricing models, where the data is generated by the solution that the OSCAR project develops, and where pricing agreements are rooted in the documented treatment effect that patients experience through treatment in Danish hospitals.
Roche logo
Roche, in collaboration with DataFair, are the co-initiators of the OSCAR project. Through OSCAR, Roche wishes to contribute to improved access to and utilisation of Danish health data in validated clinical research initiatives. Ultimately, Roche’s goal is to promote the implementation of precision medicine in clinical practice, as well as to develop and test new innovative, outcomes-based reimbursement for pharmaceuticals commensurate with the value of the treatment options patients are given.

Public advisors

The project is advised by a public and a private advisory board. In the public advisory board the following organisations are represented:

Private advisors

The private advisory board for the OSCAR project includes representatives from following companies: